REGENTS OF THE UNIVERSITY OF CALIFORNIA - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 76 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
REGENTS OF THE UNIVERSITY OF CALIFORNIA ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,243
-12.1%
53,5540.0%0.00%0.0%
Q2 2023$18,476
-56.1%
53,5540.0%0.00%
-75.0%
Q1 2023$42,040
-21.5%
53,5540.0%0.01%
-20.0%
Q4 2022$53,554
+11.6%
53,5540.0%0.01%0.0%
Q3 2022$48,000
-18.6%
53,5540.0%0.01%
-16.7%
Q2 2022$59,00053,5540.01%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,256,717$3,569,0000.16%
DOWLING & YAHNKE LLC 150,464$427,0000.04%
Aureus Asset Management, LLC 70,211$199,0000.02%
IEQ CAPITAL, LLC 72,217$205,0000.01%
Cohen Capital Management, Inc. 13,046$37,0000.01%
Creative Planning 487,737$1,385,0000.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 84,605$240,0000.00%
North Star Investment Management Corp. 4,000$11,0000.00%
DELTA ASSET MANAGEMENT LLC/TN 7$00.00%
MORGAN STANLEY 21,342$61,0000.00%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders